8-120001615-A-G
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_022783.4(DEPTOR):āc.695A>Gā(p.Asn232Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000322 in 1,613,924 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_022783.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DEPTOR | NM_022783.4 | c.695A>G | p.Asn232Ser | missense_variant | 5/9 | ENST00000286234.6 | NP_073620.2 | |
DEPTOR | NM_001283012.2 | c.392A>G | p.Asn131Ser | missense_variant | 3/7 | NP_001269941.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DEPTOR | ENST00000286234.6 | c.695A>G | p.Asn232Ser | missense_variant | 5/9 | 1 | NM_022783.4 | ENSP00000286234.5 | ||
DEPTOR | ENST00000523492.5 | c.392A>G | p.Asn131Ser | missense_variant | 3/7 | 2 | ENSP00000430457.1 | |||
DEPTOR | ENST00000518057.1 | n.144A>G | non_coding_transcript_exon_variant | 2/6 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000289 AC: 44AN: 152086Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000402 AC: 101AN: 251398Hom.: 0 AF XY: 0.000486 AC XY: 66AN XY: 135872
GnomAD4 exome AF: 0.000326 AC: 476AN: 1461838Hom.: 2 Cov.: 33 AF XY: 0.000400 AC XY: 291AN XY: 727214
GnomAD4 genome AF: 0.000289 AC: 44AN: 152086Hom.: 0 Cov.: 31 AF XY: 0.000242 AC XY: 18AN XY: 74298
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at